ArticleJournal of hepatocellular carcinoma2026

High Expression of Follistatin is a Risk Factor Predicting Poor Overall Survival in Hepatocellular Carcinoma Patients.

Yihua Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.